Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Litvan

Showing results (201-210 of 331) with videos related to

Pageof 34
Sort By:
Nature Communications|April 22, 2020
α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's diseaseCecilia S Lindestam Arlehamn, Rekha Dhanwani, John Pham, et al.
The Journal of Clinical Investigation|December 17, 2024
PINK1 is a target of T cell responses in Parkinson's diseaseGregory P Williams, Antoine Freuchet, Tanner Michaelis, et al.
Journal of the Neurological Sciences|December 10, 2022
Unaltered T cell responses to common antigens in individuals with Parkinson's diseaseGregory P Williams, Kaylin Muskat, April Frazier, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2018
Validation of the MDS clinical diagnostic criteria for Parkinson's diseaseRonald B Postuma, Werner Poewe, Irene Litvan, et al.
Acta Neuropathologica|June 22, 2018
Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtypeShunsuke Koga, Naomi Kouri, Ronald L Walton, et al.
Dementia and Geriatric Cognitive Disorders|June 19, 2013
Impact of mild cognitive impairment on health-related quality of life in Parkinson's diseaseWilliam Reginold, Sarah Duff-Canning, Christopher Meaney, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 14, 2017
Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?Jennifer L Whitwell, Günter U Höglinger, Angelo Antonini, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 26, 2012
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelinesIrene Litvan, Jennifer G Goldman, Alexander I Tröster, et al.
Plos One|August 21, 2018
Cognition among individuals along a spectrum of increased risk for Parkinson's diseaseLana M Chahine, Liz Urbe, Chelsea Caspell-Garcia, et al.
The Lancet. Neurology|June 16, 2016
The new definition and diagnostic criteria of Parkinson's diseaseRonald B Postuma, Daniela Berg, Charles H Adler, et al.
Pageof 34

Showing results (201-210 of 331) with videos related to

Sort By:
Pageof 34
Nature Communications|April 22, 2020
α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's diseaseCecilia S Lindestam Arlehamn, Rekha Dhanwani, John Pham, et al.
The Journal of Clinical Investigation|December 17, 2024
PINK1 is a target of T cell responses in Parkinson's diseaseGregory P Williams, Antoine Freuchet, Tanner Michaelis, et al.
Journal of the Neurological Sciences|December 10, 2022
Unaltered T cell responses to common antigens in individuals with Parkinson's diseaseGregory P Williams, Kaylin Muskat, April Frazier, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2018
Validation of the MDS clinical diagnostic criteria for Parkinson's diseaseRonald B Postuma, Werner Poewe, Irene Litvan, et al.
Acta Neuropathologica|June 22, 2018
Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtypeShunsuke Koga, Naomi Kouri, Ronald L Walton, et al.
Dementia and Geriatric Cognitive Disorders|June 19, 2013
Impact of mild cognitive impairment on health-related quality of life in Parkinson's diseaseWilliam Reginold, Sarah Duff-Canning, Christopher Meaney, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 14, 2017
Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?Jennifer L Whitwell, Günter U Höglinger, Angelo Antonini, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 26, 2012
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelinesIrene Litvan, Jennifer G Goldman, Alexander I Tröster, et al.
Plos One|August 21, 2018
Cognition among individuals along a spectrum of increased risk for Parkinson's diseaseLana M Chahine, Liz Urbe, Chelsea Caspell-Garcia, et al.
The Lancet. Neurology|June 16, 2016
The new definition and diagnostic criteria of Parkinson's diseaseRonald B Postuma, Daniela Berg, Charles H Adler, et al.
Pageof 34